Abstract: The invention relates to an electrooptical liquid-crystal display having a realignment layer for realigning the liquid crystals, where the field thereof has a significant component parallel to the liquid-crystal layer, containing a liquid-crystalline medium having positive dielectric anisotropy, where the medium comprises at least one mesogenic compound which contains a group of the formula I and at least one compound of formula II wherein L1 is H or F; R1 R2 are H, an alkyl or alkenyl radical having 1 to 15 carbon atoms which may be substituted; Q is a radical of the formula —(O)q (CH2)r—(CF2)s— in which q is 0 or 1; r is 0 or an integer of 1 to 6, and s is an integer of 0 to 6; X is F or Cl, and in the case where s ≠0, is alternatively H, and A1 and A2 are each, independently of one another, a 1,4-cyclohexenylene or trans-1,4-cyclohexylene which may be substituted; 1,4-phenylene in which may be substituted, 1,4-bicyclo[2.2.

Abstract: The invention relates to an electro-optical liquid-crystal display having a realignment layer for realigning the liquid crystals whose field has a significant component parallel to the liquid-crystal layer and which contains a liquid-crystalline medium of positive dielectric anisotropy, where the medium comprises at least one mesogenic compound containing a 3,4,5-trifluorophenyl group and/or comprises at least one mesogenic compound [lacuna] a structural unit of the formula 2 ##STR1## in which A is O or CH,Z is --COO-- or a single bondL.sup.1 is F or, if A is O, is alternatively H, andL.sup.2 is H or F.

Abstract: The invention relates to an electro-optical liquid-crystal display having a realignment layer for realigning the liquid crystals whose field has a significant component parallel to the liquid-crystal layer and which contains a liquid-crystalline medium of positive dielectric anisotropy, where the medium comprises at least one mesogenic compound containing a 3,4,5-trifluorophenyl group and/or comprises at least one mesogenic compound [lacuna] a structural unit of the formula 2 ##STR1## in which A is O or CH,z is --COO-- or a single bondL.sup.1 is F or, if A is O, is alternatively H, andL.sup.2 is H or F.